MD Start
Overview
MD Start is a European medtech accelerator that creates and supports new medical technology companies by providing initial funding and hands-on support. It operates as a joint effort with Sofinnova Partners, a European life sciences venture capital firm. The firm sources innovations from academia and clinicians to build companies from the ground up. It has raised several funds, including MD Start I (€8.2M), MD Start II (€10.3M), and Sofinnova MD Start III (€63M).
Portfolio Companies
3
Website
mdstart.euInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moon Surgical | May 2023 | Series B | - |
| HEPTA Medical | - | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Key People
Anne Osdoit
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MD Start based?
MD Start is headquartered in France.
When was MD Start founded?
Founding year information for MD Start is not publicly available.
How many portfolio companies does MD Start have?
MD Start has 3 portfolio companies in Caplight's dataset.
What are some companies in MD Start's portfolio?
Portfolio companies visible on Caplight include Moon Surgical, HEPTA Medical.
What was MD Start's most recent investment shown here?
MD Start's most recent investment in this portfolio sample was in Moon Surgical in 2023.
What sectors does MD Start focus on?
MD Start focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does MD Start focus on?
MD Start typically invests at the Early stage.
What is MD Start's AUM?
MD Start's assets under management are estimated between $81.5M and $90.0M.